Mental health neurostimulation company Nexalin is going public with a $9.6 million initial public offering.
Nexalin is offering 2,315,000 shares of common stock at $4.15 per share. Nexalin will trade under the ticker name "NXL," according to the Sept. 15 company news release.
Trading for Nexalin on the Nasdaq is set to begin Sept. 20.